Rifampin
Showing 501 - 525 of 564
Tuberculosis Trial in Dasmariñas City (Myrin© 2 (Rifampicin + Isoniazid), Rimactane® (Rifampicin))
Completed
- Tuberculosis
- Myrin© 2 (Rifampicin + Isoniazid)
- Rimactane® (Rifampicin)
-
Dasmariñas City, PhilippinesPfizer Investigational Site
Jun 21, 2012
Latent Tuberculosis Infection Trial in Tainan, Taipei (4-month rifampin vs. 9-month isoniazid)
Unknown status
- Latent Tuberculosis Infection
- 4-month rifampin vs. 9-month isoniazid
-
Tainan, Taiwan
- +1 more
Jul 19, 2011
Tuberculosis Trial in Worldwide (Moxifloxacin (with rifampin, pyrazinamide, and ethambutol), isoniazid)
Completed
- Tuberculosis
- Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)
- isoniazid
-
Little Rock, Arkansas
- +25 more
Aug 2, 2011
Tuberculosis Trial in Canada, United States (Rifampin, Pyrazinamide, Ethambutol)
Completed
- Tuberculosis
- Rifampin
- +3 more
-
Little Rock, Arkansas
- +22 more
Aug 2, 2011
Tuberculosis, Aids, Hiv Infections Trial in Maputo (Nevirapine based therapy, Efavirenz based therapy, Rifampicin (RMP)
Completed
- Tuberculosis
- +2 more
- Nevirapine based therapy
- +2 more
-
Maputo, Mozambique
- +2 more
Feb 14, 2012
Patients With Drug Resistant Acinetobacter Baumannii Bacteremia
Unknown status
- Acinetobacter Bacteraemia
-
Douliou, Taiwan
- +2 more
Jan 17, 2012
Drug Induced Hepatotoxicity, Tuberculosis Trial in Tirupati, New Delhi (Rifampicin(max dose 10 mg/kg/day), Isoniazide (max dose
Completed
- Drug Induced Hepatotoxicity
- Tuberculosis
- Rifampicin(max dose 10 mg/kg/day), Isoniazide (max dose 5 mg/kg/day) and Pyrazinamide (max dose 25 mg/kg/day)
-
Tirupati, Andhra Pradesh, India
- +1 more
Feb 14, 2012
HIV, AIDS, Tuberculosis Trial in New Delhi (INH, Rifampicin, Ethambutol and Pyrazinamide)
Completed
- HIV Infections
- +2 more
- INH, Rifampicin, Ethambutol and Pyrazinamide
-
New Delhi, IndiaAll India Institute of Medcial Sciences
Nov 5, 2011
HIV, Tuberculosis Trial in United States (Ethambutol HCl, Isoniazid, Pyrazinamide)
Completed
- HIV Infections
- Tuberculosis
- Ethambutol hydrochloride
- +4 more
-
Los Angeles, California
- +12 more
Mar 1, 2011
HIV, Tuberculosis Trial in Salvador (efavirenz or nevirapine)
Terminated
- HIV Infections
- Tuberculosis
- efavirenz or nevirapine
-
Salvador, Bahia, BrazilHospital Universitario Prof. Edgard Santos/Universidade Federal
Jul 20, 2011
Invasive Aspergillosis Trial in Seoul (Voriconazole)
Completed
- Invasive Aspergillosis
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trial Center
Aug 17, 2011
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in Worldwide (bortezomib, bortezomib, rifampicin, bortezomib, dexamethasone)
Completed
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
- bortezomib
- +2 more
-
Petach Tikva, Israel
- +8 more
Jan 26, 2012
Healthy Trial in New Haven (Tasocitinib (CP-690,550) plus Rifampin)
Completed
- Healthy
- Tasocitinib (CP-690,550) plus Rifampin
-
New Haven, ConnecticutPfizer Investigational Site
Oct 21, 2010
Healthy Male Volunteers Trial in Seoul (Ketoconazole, rifampicin)
Completed
- Healthy Male Volunteers
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 31, 2011
Tuberculosis Trial in Taoyuan (isoniazid , randomized, open label, rifampin, randomized, open label)
Completed
- Tuberculosis
- isoniazid , randomized, open label
- rifampin, randomized, open label
-
Taoyuan, TaiwanTaipei Prison
Nov 25, 2010
Rheumatoid Arthritis, Healthy Volunteers Trial in Overland Park (fostamatinib, rifampicin)
Completed
- Rheumatoid Arthritis
- Healthy Volunteers
-
Overland Park, KansasResearch Site
Jul 21, 2011
Healthy Subjects Trial in Jerusalem (Rifampicin)
Unknown status
- Healthy Subjects
-
Jerusalem, IsraelHadassah Hebrew University Medical Center
Jul 5, 2011
CYP3A4 Induction Trial in Stockholm (Rifampicin treatment)
Completed
- CYP3A4 Induction
- Rifampicin treatment
-
Stockholm, SwedenClinical Pharmacology Trial Unit (CPTU), Karolinska University H
Jul 8, 2011
Tuberculosis Trial in Rio de Janeiro (Isoniazid, Pyrazinamide, Rifampin)
Completed
- Tuberculosis
- Isoniazid
- +2 more
-
Rio de Janeiro, BrazilMunicipal Health Department
Aug 26, 2010
Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
Completed
- Drug Resistance, Microbial
- None - Observational study
-
Brooklyn, New YorkMaimonides Medical Center
Aug 18, 2011
Tuberculosis, HIV Trial in Moshi (Emtricitabine/tenofovir/efavirenz)
Unknown status
- Tuberculosis
- HIV Infections
-
Moshi, Kilimanjaro Region, TanzaniaKibong'oto National Tuberculosis Hospital
Dec 16, 2010
Pulmonary Tuberculosis Trial in Taipei (Rifater and EMB)
Unknown status
- Pulmonary Tuberculosis
- Rifater and EMB
-
Taipei, TaiwanTaipei Medical University- Wan Fang Hospital
Apr 11, 2011